日本リウマチ学会   評議員  

2023.4   

日本小児リウマチ学会   理事  

2022.4 - 2023.12   

日本小児リウマチ学会   情報化委員会委員  

2021.9 - 2023.8   

日本小児リウマチ学会   倫理委員会委員  

2021.9 - 2023.8   

Kobayashi I, Akioka S, Kobayashi N, Iwata N, Takezaki S, Nakaseko H, Sato S, Nishida Y, Nozawa T, Yamasaki Y, Yamazaki K, Arai S, Nishino I, Mori M. .  Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-update. .  Modern Rheumatology   2020Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-update.Reviewed

Yamazaki K, Ohta A, Akioka S, Yamasaki Y, Ohara A, Nakaseko H, Nishimura K, Kobayashi N, Nishida Y, Sato S, Takezaki S, Kishi T, Hashimoto M, Kobayashi I, Mori M. .  External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort. .  Rheumatology (Oxford)   2020External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort.Reviewed

Yamasaki Y, Kubota T, Takei S, Imanaka H, Nonaka Y, Kawano Y. .  A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease. .  Clinical Rheumatology   2020A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease.Reviewed

米衛 ちひろ, 丸山 慎介, 馬場 悠生, 佐野 のぞみ, 山崎 雄一, 武井 修治 .  舞踏運動で初発した全身性エリテマトーデスの2例 .  脳と発達   2020舞踏運動で初発した全身性エリテマトーデスの2例

Yamasaki Y, Takei S, Imanaka H, Kubota T, Nonaka Y, Takezaki T, Kawano Y .  S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis. .  Clinical Rheumatology   2019S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis.Reviewed

Hara R, Umebayashi H, Takei S, Okamoto N, Iwata N, Yamasaki Y, Nakagishi Y, Kizawa T, Kobayashi I, Imagawa T, Kinjo N, Amano N, Takahashi Y, Mori M, Itoh Y, Yokota S .  Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study. .  Pediatric Rheumatology Online Journal   2019Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.Reviewed

Imamura M, Okamoto Y, Nishikawa T, Yoneyama T, Yamasaki Y, Kawamura J, Kawano Y .  Celecoxib as a Potential Treatment for Intractable Lymphatic Malformation. .  Pediatrics   2019Celecoxib as a Potential Treatment for Intractable Lymphatic Malformation.Reviewed

Kubota T, Takei S, Shimizu M, Yasumura J, Nakagishi Y, Kizawa T, Yashiro M, Wakiguchi H, Yamasaki Y, Kawano Y. .  Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan. .  Modern Rheumatology   2018Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan.Reviewed

今村真理、山﨑雄一、川村順平 .  育児過誤と鑑別が必要であった十二指腸閉鎖症の1か月女児例 .  小児科臨床   2018育児過誤と鑑別が必要であった十二指腸閉鎖症の1か月女児例

Nagakura T, Wakiguchi H, Kubota T, Yamatou T, Yamasaki Y, Nonaka Y, Nerome Y, Akaike H, Takezaki T, Imanaka H, Kawano Y, Takei S. .  Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and YoungAdult Patients with Blau Syndrome. .  The Journal of Rheumatology   2017Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and YoungAdult Patients with Blau Syndrome.Reviewed

Kubota T, Imanaka H, Takei S, Yamatou T, Nerome Y, Yamasaki Y, Nonaka Y, Akaike H, Takezaki T, Kawano Y. .  Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis. .  Modern Rheumatology   2016 Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis.Reviewed

Nerome Y, Akaike H, Nonaka Y, Takezaki T, Kubota T, Yamato T, Yamasaki Y, Imanaka H, Kawano Y, Takei S. .  The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritiscontrolled by treatment. .  Modern Rheumatology   2016The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritiscontrolled by treatment.Reviewed

Wakiguchi H, Takei S, Imanaka H, Hiraki T, Higashi M, Yamatou T, Yamasaki Y, Kubota T, Kawano Y. .  Severe gluteal skin ulcers in an infant with juvenile dermatomyositis. .  The European Journal of Dermatology   2016Severe gluteal skin ulcers in an infant with juvenile dermatomyositis.Reviewed

Yamasaki Y, Takei S, Imanaka H, Nerome Y, Kubota T, Nonaka Y, Akaike H, Takezaki T, Kawano Y. .  Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and Vascular Endothelial Growth Factor .  Modern Rheumatology   2015Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and Vascular Endothelial Growth FactorReviewed

Shimizu M, Nakagishi Y, Inoue N, Mizuta M, Ko G, Saikawa Y, Kubota T, Yamasaki Y, Takei S, Yachie A. .  Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. .  Clinical Immunology   2015Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis.Reviewed

池田 尚弘, 丸山 慎介, 中野 緩奈, 今給黎 亮, 関 俊二, 山崎 雄一, 二宮 由美子, 田邊 貴幸, 河野 嘉文 .  新生児期に発症し、救命し得たCarnitine palmitoyltransferase II(CPTII)欠損症の1例 .  日本小児科学会雑誌119 ( 5 )   2015新生児期に発症し、救命し得たCarnitine palmitoyltransferase II(CPTII)欠損症の1例 Reviewed

Shimizu M, Nakagishi Y, Kasai K, Yamasaki Y, Miyoshi M, Takei S, Yachie A. .  Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. .  Cytokine   2012Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6.Reviewed

倉内宏一郎、山﨑雄一、田中主美、上村隆雄. .  化膿性髄膜炎からBroca失語をきたした１例 .  小児科30 ( 1 ) 69 - 72   2009化膿性髄膜炎からBroca失語をきたした１例Reviewed

Yamasaki Y, Nishi J, Nishikawa T, Tatsumoto C, Kasano F, Sano N, Kawano Y, Kawakami K .  Descending necrotizing mediastinitis secondary to retropharyngeal abscess in a child .  The Journal of Infection and Chemotherapy   2008Descending necrotizing mediastinitis secondary to retropharyngeal abscess in a childReviewed

Kubota Tomohiro, Takei Syuji, Yamato Tsuyoshi, Yamasaki Yuichi, Kawano Yoshifumi .  指骨マイクロジオディック症候群における超音波画像　1症例報告(Ultrasonographic imaging in phalangeal microgeodic syndrome: a case report) .  Modern Rheumatology Case Reports3 ( 1 ) 67 - 69   2019.1指骨マイクロジオディック症候群における超音波画像　1症例報告(Ultrasonographic imaging in phalangeal microgeodic syndrome: a case report)

Kubota Tomohiro, Takei Syuji, Shimizu Masaki, Yasumura Junko, Nakagishi Yasuo, Kizawa Toshitaka, Yashiro Masato, Wakiguchi Hiroyuki, Yamasaki Yuichi, Kawano Yoshifumi .  多関節型若年性特発性関節炎に対して初回導入した生物学的製剤の2年以上の有効性に関する早期予測　日本における多施設共同研究(Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan) .  Modern Rheumatology28 ( 5 ) 826 - 831   2018.9多関節型若年性特発性関節炎に対して初回導入した生物学的製剤の2年以上の有効性に関する早期予測　日本における多施設共同研究(Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan)

Blau症候群

山﨑雄一, 他

小児リウマチ学   2020.4

若年性皮膚筋炎診療の手引き

山﨑雄一, 他

若年性皮膚筋炎診療の手引き   2018.5

若年性特発性関節炎と免疫抑制薬／生物学的製剤

山﨑雄一, 他

小児科   2016

小児科臨床実習における学生の担当患者数と学生による実習評価との関連. Reviewed

野村裕一、山﨑雄一、児玉祐一、新小田雄一、江口太助、田邊貴幸、徳田浩一、豊島光雄、岡本康裕、河野嘉文

日本小児科学会雑誌   2011

膠原病に見られる発疹

山﨑雄一, 他

小児内科   2010

SLEにおける肺出血

山﨑雄一, 武井修治

小児リウマチ   2010

若年性皮膚筋炎(JDM)診療の手引き2018年版　最新情報(Clinical practice guidance for juvenile dermatomyositis(JDM) 2018-Update)

Kobayashi Ichiro, Akioka Shinji, Kobayashi Norimoto, Iwata Naomi, Takezaki Shunichiro, Nakaseko Haruna, Sato Satoshi, Nishida Yutaka, Nozawa Tomo, Yamasaki Yuichi, Yamazaki Kazuko, Arai Satoru, Nishino Ichizo, Mori Masaaki

Modern Rheumatology   30 ( 3 )   411 - 423   2020.5

山﨑雄一   若年性特発性関節炎～自己免疫疾患なのか、自己炎症性疾患なのか～   Invited

第119回日本小児科学会学術集会 

山﨑雄一   s-JIAの治療方針   Invited

第21回日本小児リウマチ学会 

山﨑雄一   JIA患者に対するトシリズマブ使用のこつ　TCZ投与中におけるMAS早期診断の試み   Invited

第19回日本小児リウマチ学会  2009.10 

山﨑雄一   イラリス治療中にMASへ移行したsJIAの1例   Invited

Nation wide symposia for sJIA  2018.12 

山﨑雄一   Drug-free寛解、Bio-Free寛解は可能か   Invited

第20回日本小児リウマチ学会  2011.2